HealthPolitics
STAT+: GOP, MAHA leaders clash over FDA nominee’s record on vapes
Publication: STAT
Author: Margaret Manto and Chelsea Cirruzzo
Source published: 17/11/2026, 18:14:50 UTC
Briefing created: 17/11/2026, 22:04:54 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 17/11/2026, 18:36:24 UTC.
Briefings
A conflict between GOP factions emerged over Heidi Overton's potential nomination as FDA Commissioner, specifically regarding her role in President Trump's 2025 push to relax flavored vape regulations. Former FDA Commissioner Marty Makary resigned due to disagreements on this issue, creating the vacancy Overton would fill. Former MAHA leader Calley Means stated Overton wrote a policy relaxing fruit-flavored vape standards, noting both women worked in the White House. The article notes the GOP is divided on health policy, which could impact the party's ability to confirm an FDA leader during the lame duck period.
Key points
- Former FDA Commissioner Marty Makary resigned after clashing with President Trump over the issue of flavored vapes.
- Former MAHA leader Calley Means stated Heidi Overton wrote a policy relaxing standards for fruit-flavored vapes.
Context
The article discusses the 2025 political landscape where GOP health policy divides threaten the party's confirmation chances for an FDA leader during the lame duck period.
Limitations
Evidence covers only the vaping policy dispute and Makary's resignation; no specific dates for the policy release, no quotes from Overton or Means, and no data on the impact of the conflict on the party's confirmation chances.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 17/11/2026, 22:04:54 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
IPFS archive pending.